{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:57:02Z","timestamp":1787590622354,"version":"build-2736575974"},"reference-count":101,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.aohep.2022.100874","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T04:06:46Z","timestamp":1668053206000},"page":"100874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["What do we know about nutrient-based strategies targeting molecular mechanisms associated with obesity-related fatty liver disease?"],"prefix":"10.1016","volume":"28","author":[{"given":"Ingrid","family":"Rivera-I\u00f1iguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Panduro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Gonz\u00e1lez-Aldaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2022.100874_bib0001","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.dld.2010.01.016","article-title":"From the metabolic syndrome to NAFLD or vice versa?","volume":"42","author":"Vanni","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.aohep.2022.100874_bib0002","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"issue":"Suppl 3","key":"10.1016\/j.aohep.2022.100874_bib0003","first-page":"52","article-title":"Nonalcoholic fatty liver disease","volume":"70","author":"Angulo","year":"2005","journal-title":"Rev Gastroenterol Mexico"},{"key":"10.1016\/j.aohep.2022.100874_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2022.100706","article-title":"Nonalcoholic fatty liver disease prevalence in Latin America: a systematic review and meta-analysis","author":"Rojas","year":"2022","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.aohep.2022.100874_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208926","article-title":"High prevalence of nonalcoholic steatohepatitis and abnormal liver stiffness in a young and obese Mexican population","volume":"14","author":"Sepulveda-Villegas","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.aohep.2022.100874_bib0006","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/MPG.0b013e31818e04d1","article-title":"Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: a systematic review","volume":"48","author":"Socha","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.aohep.2022.100874_bib0007","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/07853890.2010.547869","article-title":"Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: pathogenetic role of genetic background and intrauterine environment","volume":"44","author":"Alisi","year":"2012","journal-title":"Ann Med"},{"key":"10.1016\/j.aohep.2022.100874_bib0008","doi-asserted-by":"crossref","first-page":"1499S","DOI":"10.3945\/ajcn.2010.28701B","article-title":"Childhood obesity and adult morbidities","volume":"91","author":"Biro","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.aohep.2022.100874_bib0009","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1111\/liv.14675","article-title":"MAFLD identifies patients with significant hepatic fibrosis better than NAFLD","volume":"40","author":"Yamamura","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2022.100874_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112956","article-title":"Downregulation of hepatic fat accumulation, inflammation and fibrosis by nerolidol in purpose built western-diet-induced multiple-hit pathogenesis of NASH animal model","volume":"150","author":"Sabir","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.aohep.2022.100874_bib0011","article-title":"The NLRP3 inflammasome in nonalcoholic fatty liver disease and steatohepatitis: therapeutic targets and treatment","volume":"13","author":"Yu","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.aohep.2022.100874_bib0012","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1301\/nr.2007.jun.S57-S63","article-title":"Obesity and nonalcoholic fatty liver disease","volume":"65","author":"Angulo","year":"2007","journal-title":"Nutr Rev"},{"key":"10.1016\/j.aohep.2022.100874_bib0013","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1136\/jim-2017-000524","article-title":"Influence of dietary macronutrients on liver fat accumulation and metabolism","volume":"65","author":"Parry","year":"2017","journal-title":"J Investig Med"},{"key":"10.1016\/j.aohep.2022.100874_bib0014","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J Clin Invesig"},{"key":"10.1016\/j.aohep.2022.100874_bib0015","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.2337\/diabetes.54.12.3458","article-title":"Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver","volume":"54","author":"Boden","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.aohep.2022.100874_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.755505","article-title":"NEFAs Influence the Inflammatory and Insulin Signaling Pathways Through TLR4 in Primary Calf Hepatocytes in vitro","volume":"8","author":"Deng","year":"2021","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.aohep.2022.100874_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101428","article-title":"CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing","volume":"57","author":"Zeng","year":"2022","journal-title":"Mol Metab"},{"key":"10.1016\/j.aohep.2022.100874_bib0018","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2018.01.019","article-title":"Fructose and sugar: a major mediator of nonalcoholic fatty liver disease","volume":"68","author":"Jensen","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2022.100874_bib0019","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/s42255-021-00489-2","article-title":"Peroxisomal \u03b2-oxidation acts as a sensor for intracellular fatty acids and regulates lipolysis","volume":"3","author":"Ding","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.aohep.2022.100874_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2008.08.001","article-title":"Recent insights into hepatic lipid metabolism in nonalcoholic fatty liver disease (NAFLD)","volume":"48","author":"Musso","year":"2009","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.aohep.2022.100874_bib0021","doi-asserted-by":"crossref","DOI":"10.1002\/hep.32324","article-title":"Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD","author":"Moore","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2022.100874_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.783393","article-title":"The contribution of dietary fructose to non-alcoholic fatty liver disease","volume":"12","author":"Yu","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.aohep.2022.100874_bib0023","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201900482","article-title":"Metabolic inflammation in obesity-at the crossroads between fatty acid and cholesterol metabolism","volume":"65","author":"Curley","year":"2021","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.aohep.2022.100874_bib0024","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2020.07.041","article-title":"Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis","volume":"74","author":"Gaul","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2022.100874_bib0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10565-019-09496-2","article-title":"Cell death mechanisms in eukaryotes","volume":"36","author":"Nirmala","year":"2020","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.aohep.2022.100874_bib0026","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.aohep.2022.100874_bib0027","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.aohep.2022.100874_bib0028","first-page":"1","article-title":"AS3MT facilitates NLRP3 inflammasome activation by m(6)A modification during arsenic-induced hepatic insulin resistance","author":"Qiu","year":"2022","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.aohep.2022.100874_bib0029","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of hepatic mitochondrial function in humans with nonalcoholic fatty liver is lost in steatohepatitis","volume":"21","author":"Koliaki","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.aohep.2022.100874_bib0030","doi-asserted-by":"crossref","DOI":"10.1007\/s13679-022-00473-1","article-title":"Hepatocyte mitochondrial dynamics and bioenergetics in obesity-related nonalcoholic fatty liver disease","author":"Legaki","year":"2022","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.aohep.2022.100874_bib0031","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136848","article-title":"The alterations of mitochondrial function during NAFLD progression-an independent effect of mitochondrial ROS production","volume":"22","author":"Sim\u00f5es","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.aohep.2022.100874_bib0032","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9986299","article-title":"Changes in key mitochondrial lipids accompany mitochondrial dysfunction and oxidative stress in NAFLD","volume":"2021","author":"Durand","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.aohep.2022.100874_bib0033","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/1756283X13482996","article-title":"Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ","volume":"6","author":"Guinane","year":"2013","journal-title":"Ther Adv Gastroenterol"},{"key":"10.1016\/j.aohep.2022.100874_bib0034","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.cell.2006.02.017","article-title":"Ecological and evolutionary forces shaping microbial diversity in the human intestine","volume":"124","author":"Ley","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.aohep.2022.100874_bib0035","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/hep.28864","article-title":"Nonalcoholic steatohepatitis and the intestinal microbiota","volume":"65","author":"Haslam","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2022.100874_bib0036","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2022.100874_bib0037","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00248-010-9801-8","article-title":"Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients","volume":"61","author":"Lu","year":"2011","journal-title":"Microb Ecol"},{"key":"10.1016\/j.aohep.2022.100874_bib0038","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fcimb.2012.00136","article-title":"Human gut microbiota: repertoire and variations","volume":"2","author":"Lagier","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.aohep.2022.100874_bib0039","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/hep.31755","article-title":"Microbiota-driven activation of intrahepatic B cells aggravates NASH through innate and adaptive signaling","volume":"74","author":"Barrow","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2022.100874_bib0040","article-title":"Macrophage-derived thrombospondin 1 promotes obesity-associated nonalcoholic fatty liver disease","volume":"3","author":"Gwag","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.aohep.2022.100874_bib0041","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2010.03.052","article-title":"Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice","volume":"139","author":"Miura","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2022.100874_bib0042","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","article-title":"The role of the gut microbiota in NAFLD","volume":"13","author":"Leung","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2022.100874_bib0043","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jceh.2015.02.002","article-title":"The riddle of nonalcoholic fatty liver disease: progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis","volume":"5","author":"Sharma","year":"2015","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.aohep.2022.100874_bib0044","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/ncomms2852","article-title":"The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43","volume":"4","author":"Kimura","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.aohep.2022.100874_bib0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5152\/tjg.2014.7886","article-title":"Role of gut microbiota: obesity and NAFLD","volume":"25","author":"Gangarapu","year":"2014","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.aohep.2022.100874_bib0046","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.cmet.2015.09.028","article-title":"Microbiota-dependent hepatic lipogenesis mediated by stearoyl CoA desaturase 1 (SCD1) promotes metabolic syndrome in TLR5-deficient mice","volume":"22","author":"Singh","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.aohep.2022.100874_bib0047","doi-asserted-by":"crossref","DOI":"10.3390\/nu13124203","article-title":"The effects of butyrate on induced metabolic-associated fatty liver disease in precision-cut liver slices","volume":"13","author":"Prins","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.aohep.2022.100874_bib0048","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.0407076101","article-title":"The gut microbiota as an environmental factor that regulates fat storage","volume":"101","author":"B\u00e4ckhed","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.aohep.2022.100874_bib0049","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1254\/jphs.13R09CP","article-title":"Inter-organ communication in the regulation of lipid metabolism: focusing on the network between the liver, intestine, and heart","volume":"123","author":"Ito","year":"2013","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.aohep.2022.100874_bib0050","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1128\/MCB.00858-12","article-title":"Short-chain fatty acids stimulate angiopoietin-like 4 synthesis in human colon adenocarcinoma cells by activating peroxisome proliferator-activated receptor \u03b3","volume":"33","author":"Alex","year":"2013","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.aohep.2022.100874_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115333","article-title":"Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice","volume":"294","author":"Li","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.aohep.2022.100874_bib0052","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.3390\/nu12082340","article-title":"The relationship between choline bioavailability from diet, intestinal microbiota composition, and its modulation of human diseases","volume":"12","author":"Arias","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.aohep.2022.100874_bib0053","doi-asserted-by":"crossref","first-page":"19076","DOI":"10.1038\/srep19076","article-title":"Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with nonalcoholic fatty liver disease in adults","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.aohep.2022.100874_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2020.07.010","article-title":"Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes","volume":"47","author":"Le\u00f3n-Mimila","year":"2021","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.aohep.2022.100874_bib0055","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/liv.14402","article-title":"Metabolic regulation of hepatic PNPLA3 expression and severity of liver fibrosis in patients with NASH","volume":"40","author":"Bruschi","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2022.100874_bib0056","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/hep.30583","article-title":"PNPLA3, CGI-58, and inhibition of hepatic triglyceride hydrolysis in mice","volume":"69","author":"Wang","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2022.100874_bib0057","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.3945\/ajcn.2010.30185","article-title":"Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption","volume":"92","author":"Davis","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.aohep.2022.100874_bib0058","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.3390\/nu13051621","article-title":"PNPLA3 genotype, arachidonic acid intake, and unsaturated fat intake influences liver fibrosis in hispanic youth with obesity","volume":"13","author":"Jones","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.aohep.2022.100874_bib0059","doi-asserted-by":"crossref","first-page":"e37827","DOI":"10.1371\/journal.pone.0037827","article-title":"Hepatic fat accumulation is modulated by the interaction between the rs738409 variant in the PNPLA3 gene and the dietary omega6\/omega3 PUFA intake","volume":"7","author":"Santoro","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.aohep.2022.100874_bib0060","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s12263-014-0388-4","article-title":"The PNPLA3 Ile148Met interacts with overweight and dietary intakes on fasting triglyceride levels","volume":"9","author":"Stojkovic","year":"2014","journal-title":"Genes Nutr"},{"key":"10.1016\/j.aohep.2022.100874_bib0061","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202101115","article-title":"ChREBP-driven DNL and PNPLA3 expression induced by liquid fructose are essential in the production of fatty liver and hypertriglyceridemia in a high-fat diet-fed rat model","volume":"66","author":"Vel\u00e1zquez","year":"2022","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.aohep.2022.100874_bib0062","doi-asserted-by":"crossref","first-page":"994","DOI":"10.14309\/ajg.0000000000001072","article-title":"Impact of the association between PNPLA3 genetic variation and dietary intake on the risk of significant fibrosis in patients with NAFLD","volume":"116","author":"Vilar-Gomez","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aohep.2022.100874_bib0063","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jhep.2015.07.036","article-title":"Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: results from the WELCOME trial","volume":"63","author":"Scorletti","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2022.100874_bib0064","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000441185","article-title":"Reduction of caloric intake might override the prosteatotic effects of the PNPLA3 p.I148M and TM6SF2 p.E167K variants in patients with fatty liver: ultrasound-based prospective study","volume":"93","author":"Krawczyk","year":"2016","journal-title":"Digestion"},{"key":"10.1016\/j.aohep.2022.100874_bib0065","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000502008","article-title":"Four-week Omega-3 supplementation in carriers of the prosteatotic PNPLA3 p.I148M genetic variant: an open-label study","volume":"12","author":"Kuttner","year":"2019","journal-title":"Lifestyle Genom"},{"key":"10.1016\/j.aohep.2022.100874_bib0066","doi-asserted-by":"crossref","first-page":"634","DOI":"10.17235\/reed.2018.5602\/2018","article-title":"Role of the PNPLA3 polymorphism rs738409 on silymarin\u00a0+\u00a0vitamin E response in subjects with nonalcoholic fatty liver disease","volume":"110","author":"Aller","year":"2018","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.aohep.2022.100874_bib0067","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3945\/ajcn.112.038695","article-title":"Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans","volume":"96","author":"Sevastianova","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.aohep.2022.100874_bib0068","doi-asserted-by":"crossref","DOI":"10.3390\/genes12050628","article-title":"The effect of genetic polymorphism in response to body weight reduction in Japanese patients with nonalcoholic fatty liver disease","volume":"12","author":"Seko","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.aohep.2022.100874_bib0069","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.49882","article-title":"Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives nonalcoholic fatty liver disease","volume":"8","author":"Helsley","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.aohep.2022.100874_bib0070","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1053\/j.gastro.2016.01.032","article-title":"The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent","volume":"150","author":"Mancina","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2022.100874_bib0071","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1038\/s41598-018-23453-9","article-title":"Lack of evidence supporting a role of TMC4-rs641738 missense variant-MBOAT7- intergenic downstream variant-in the susceptibility to nonalcoholic fatty liver disease","volume":"8","author":"Sookoian","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.aohep.2022.100874_bib0072","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.numecd.2021.01.020","article-title":"Association between MBOAT7 rs641738 polymorphism and nonalcoholic fatty liver in overweight or obese children","volume":"31","author":"Zusi","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.aohep.2022.100874_bib0073","doi-asserted-by":"crossref","DOI":"10.3390\/nu10111600","article-title":"Fat mass and obesity associated (FTO) gene and hepatic glucose and lipid metabolism","volume":"10","author":"Mizuno","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.aohep.2022.100874_bib0074","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1002\/jcb.26746","article-title":"FTO reduces mitochondria and promotes hepatic fat accumulation through RNA demethylation","volume":"119","author":"Kang","year":"2018","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.aohep.2022.100874_bib0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12944-022-01640-y","article-title":"Fat mass and obesity-associated protein promotes liver steatosis by targeting PPAR\u03b1","volume":"21","author":"Wei","year":"2022","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.aohep.2022.100874_bib0076","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146224","article-title":"FTO knockout in adipose tissue effectively alleviates hepatic steatosis partially via increasing the secretion of adipocyte-derived IL-6","volume":"818","author":"Zeng","year":"2022","journal-title":"Gene"},{"key":"10.1016\/j.aohep.2022.100874_bib0077","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.2147\/CIA.S254740","article-title":"FTO polymorphisms are associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) susceptibility in the older chinese han population","volume":"15","author":"Gu","year":"2020","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.aohep.2022.100874_bib0078","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jhep.2019.10.011","article-title":"\u03b2-Klotho gene variation is associated with liver damage in children with NAFLD","volume":"72","author":"Dongiovanni","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2022.100874_bib0079","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103249","article-title":"The KLB rs17618244 gene variant is associated with fibrosing MAFLD by promoting hepatic stellate cell activation","volume":"65","author":"Panera","year":"2021","journal-title":"eBioMedicine"},{"key":"10.1016\/j.aohep.2022.100874_bib0080","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.bbalip.2008.07.005","article-title":"Inhibition of carboxylesterase 1 is associated with cholesteryl ester retention in human THP-1 monocyte\/macrophages","volume":"1781","author":"Crow","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.aohep.2022.100874_bib0081","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1194\/jlr.M800277-JLR200","article-title":"Hepatic overexpression of cholesteryl ester hydrolase enhances cholesterol elimination and in vivo reverse cholesterol transport","volume":"49","author":"Zhao","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.aohep.2022.100874_bib0082","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.bbalip.2018.04.002","article-title":"Genetic variation in human carboxylesterase CES1 confers resistance to hepatic steatosis","volume":"1863","author":"Lian","year":"2018","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"10.1016\/j.aohep.2022.100874_bib0083","doi-asserted-by":"crossref","first-page":"13984","DOI":"10.1038\/s41598-021-93549-2","article-title":"Copy number variation in the CES1 gene and the risk of nonalcoholic fatty liver in a Chinese Han population","volume":"11","author":"Chen","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.aohep.2022.100874_bib0084","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1053\/j.gastro.2009.01.048","article-title":"Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction","volume":"136","author":"Kirk","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2022.100874_bib0085","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1007\/s00125-018-4618-y","article-title":"A heterogeneous response of liver and skeletal muscle fat to the combination of a Paleolithic diet and exercise in obese individuals with type 2 diabetes: a randomised controlled trial","volume":"61","author":"Otten","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.aohep.2022.100874_bib0086","doi-asserted-by":"crossref","first-page":"e00316","DOI":"10.14309\/ctg.0000000000000316","article-title":"Moderate-intensity aerobic vs resistance exercise and dietary modification in patients with nonalcoholic fatty liver disease: a randomized clinical trial","volume":"12","author":"Charatcharoenwitthaya","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.aohep.2022.100874_bib0087","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3748\/wjg.v25.i9.1116","article-title":"Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis","volume":"25","author":"Deibert","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aohep.2022.100874_bib0088","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/ejcn.2017.9","article-title":"Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study","volume":"71","author":"Hodson","year":"2017","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.aohep.2022.100874_bib0089","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000871","article-title":"Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism","volume":"8","author":"Green","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.aohep.2022.100874_bib0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jnutbio.2019.03.006","article-title":"Pinitol consumption improves liver health status by reducing oxidative stress and fatty acid accumulation in subjects with nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial","volume":"68","author":"Lee","year":"2019","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.aohep.2022.100874_bib0091","article-title":"White tea alleviates nonalcoholic fatty liver disease by regulating energy expenditure and lipid metabolism","author":"Li","year":"2022","journal-title":"Gene"},{"key":"10.1016\/j.aohep.2022.100874_bib0092","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1007\/s10620-019-05657-9","article-title":"Vitamin E ameliorates lipid metabolism in mice with nonalcoholic fatty liver disease via Nrf2\/CES1 signaling pathway","volume":"64","author":"He","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.aohep.2022.100874_bib0093","first-page":"7449","article-title":"A randomized controlled trial comparing the effects of Vitamin E, Ursodeoxycholic acid and Pentoxifylline on Egyptian nonalcoholic steatohepatitis patients","volume":"25","author":"Fouda","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.aohep.2022.100874_bib0094","doi-asserted-by":"crossref","DOI":"10.3390\/nu13020652","article-title":"A novel nutraceuticals mixture improves liver steatosis by preventing oxidative stress and mitochondrial dysfunction in a NAFLD model","volume":"13","author":"Sangineto","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.aohep.2022.100874_bib0095","doi-asserted-by":"crossref","DOI":"10.3390\/nu9080870","article-title":"Effect of mediterranean diet and antioxidant formulation in nonalcoholic fatty liver disease: a randomized study","volume":"9","author":"Abenavoli","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.aohep.2022.100874_bib0096","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1007\/s10620-015-3770-1","article-title":"Lactobacillus paracasei Induces M2-dominant kupffer cell polarization in a mouse model of nonalcoholic steatohepatitis","volume":"60","author":"Sohn","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.aohep.2022.100874_bib0097","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1017\/S0007114517000204","article-title":"Synbiotic supplementation in lean patients with nonalcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial","volume":"117","author":"Mofidi","year":"2017","journal-title":"Br J Nutr"},{"key":"10.1016\/j.aohep.2022.100874_bib0098","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2019-000315","article-title":"High potency multistrain probiotic improves liver histology in nonalcoholic fatty liver disease (NAFLD): a randomised, double-blind, proof of concept study","volume":"6","author":"Duseja","year":"2019","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.aohep.2022.100874_bib0099","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12876-015-0400-5","article-title":"Gut microbiota manipulation with prebiotics in patients with nonalcoholic fatty liver disease: a randomized controlled trial protocol","volume":"15","author":"Lambert","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.aohep.2022.100874_bib0100","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cct.2018.05.010","article-title":"Design and rationale of the INSYTE study: a randomised, placebo controlled study to test the efficacy of a synbiotic on liver fat, disease biomarkers and intestinal microbiota in nonalcoholic fatty liver disease","volume":"71","author":"Scorletti","year":"2018","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.aohep.2022.100874_bib0101","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.3748\/wjg.v21.i12.3449","article-title":"Genome-based nutrition: an intervention strategy for the prevention and treatment of obesity and nonalcoholic steatohepatitis","volume":"21","author":"Roman","year":"2015","journal-title":"World J Gastroenterol"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268122002162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268122002162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:46:11Z","timestamp":1761648371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268122002162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":101,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1665268122002162"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2022.100874","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What do we know about nutrient-based strategies targeting molecular mechanisms associated with obesity-related fatty liver disease?","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2022.100874","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100874"}}